STAAR Surgical Company Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 3, 2026	Jan '26 Jan 2, 2026	Dec '24 Dec 27, 2024	Dec '23 Dec 29, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 31, 2021
Net Income	-21.03	-80.45	-20.21	21.35	39.67	27.51
Depreciation & Amortization	8.3	8.73	6.89	5.12	4.51	3.64
Stock-Based Compensation	29.4	30.59	27.21	23.52	20.37	14.61
Other Adjustments	20.23	23.23	10.19	8.7	0.05	0.6
Change in Receivables	-42.26	27.83	16.49	-32.76	-19.6	-8.87
Changes in Inventories	-6.59	-16.98	-10	-14.36	-7.94	0.07
Changes in Accounts Payable	-2.5	-5.51	0.08	-0.7	1.81	0.11
Changes in Accrued Expenses	-6.59	-4.56	-0.17	7.14	-0.59	7.01
Changes in Other Operating Activities	-7.56	-17.12	-15.36	-3.41	-2.55	-0.71
Operating Cash Flow	-50.19	-34.23	15.73	14.59	35.72	43.96
Operating Cash Flow Growth	-	-	7.75%	-59.14%	-18.76%	109.83%
Capital Expenditures	-4.8	-5.82	-23.39	-18.19	-18.11	-13.65
Purchases of Investments	-65.19	-75.36	-80.24	-52.31	-155.75	-
Proceeds from Sale of Investments	78.16	127.52	44.42	144.85	17.48	-
Investing Cash Flow	13.14	46.34	-59.22	74.35	-156.38	-13.65
Short-Term Debt Repaid	-	-	-	-	-	-1.3
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-	-1.3
Long-Term Debt Repaid	-	-0.04	-0.17	-0.16	-0.13	-0.35
Net Long-Term Debt Issued (Repaid)	-	-0.04	-0.17	-0.16	-0.13	-0.35
Issuance of Common Stock	3.1	3.47	7.39	9.67	8.42	19.44
Repurchase of Common Stock	-8.57	-7.98	-1.51	-2.1	-	-
Net Common Stock Issued (Repurchased)	-5.47	-4.51	5.89	7.58	8.42	19.44
Financing Cash Flow	-5.3	-4.56	5.72	7.42	8.3	17.79
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1.11	1.44	-1.11	0.2	-0.86	-0.86
Net Cash Flow	-41.25	8.99	-38.88	96.56	-113.23	47.25
Free Cash Flow	-54.99	-40.05	-7.67	-3.59	17.61	30.32
Free Cash Flow Growth	-	-	-	-	-41.92%	141.63%
FCF Margin	-18.94%	-16.73%	-2.44%	-1.11%	6.19%	13.15%
Free Cash Flow Per Share	-1.10	-0.81	-0.16	-0.07	0.36	0.61
Levered Free Cash Flow	-40.77	-121.74	-62.33	-3.21	16.66	22.34
Unlevered Free Cash Flow	-48.05	-130.94	-70.11	-6.6	15.26	25.77

SEC Filings: 10-K · 10-Q